• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Diagnostic Markets for Women’s Health: Forecasts to 2018 (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)

$995.00 – $1,990.00

Clear
SKU: KLI5367934 Categories: Diagnostics Market Research, Oncology & Hematology Market Reports Pages: 237
  • Description
  • Table of Contents
  • Latest reports

Description

Diagnostic Markets for Women’s Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)

Kalorama Information’s report on Women’s Health Diagnostic Markets takes a solid look at the current and developing world markets for key diagnostic tests aimed at the health of women. The report presents market developments in women’s health diagnostics, including in-depth analysis of the following testing fields:

  • Ovarian Cancer Testing
  • Urinary Tract Infections
  • Neonatal Jaundice
  • Autoimmune Disease
  • Cystic Fibrosis
  • Pregnancy and Ovulation Testing
  • Bone Density Testing
  • Prenatal Screening
  • Ultrasound
  • Mammography
  • Pap Smears
  • Colposcopy
  • HPV Testing

This particular study projects market growth for these tests to 2018. Market segments covered include European, US, Brazilian, Chinese and Japanese markets among others,

Globally women live longer than men. Thus healthcare systems need to change the understanding of the differences, in terms of health, between the women and men and to turn that knowledge into improved medical practice. Diagnostics are an important part of this change.

Women’s Health Diagnostic Markets also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. The report profiles several key companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing over the counter (OTC), point of care (POC) in vitro diagnostic (IVD) tests and screening systems. Some of the companies profiled include:

  • Nova Biomedical
  • Philips Healthcare
  • Siemens Healthcare
  • Somagen Diagnostics
  • GE Healthcare
  • GenMark Diagnostics
  • Hologic
  • Immco Diagnostics
  • Luminex

Sales projections are modeled on an investigation of today’s market conditions and on investigations into the development of new products by top tier competitors. The information offered in this study is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives and researchers.

Kalorama Information’s report on Women’s Health Diagnostic Markets takes a solid look at the current and developing world markets for key diagnostic tests aimed at the health of women. The report presents market developments in women’s health diagnostics, including in-depth analysis of the following testing fields:

  • Ovarian Cancer Testing
  • Urinary Tract Infections
  • Neonatal Jaundice
  • Autoimmune Disease
  • Cystic Fibrosis
  • Pregnancy and Ovulation Testing
  • Bone Density Testing
  • Prenatal Screening
  • Ultrasound
  • Mammography
  • Pap Smears
  • Colposcopy
  • HPV Testing

This particular study projects market growth for these tests to 2018. Market segments covered include European, US, Brazilian, Chinese and Japanese markets among others,

Globally women live longer than men. Thus healthcare systems need to change the understanding of the differences, in terms of health, between the women and men and to turn that knowledge into improved medical practice. Diagnostics are an important part of this change.

Women’s Health Diagnostic Markets also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. The report profiles several key companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing over the counter (OTC), point of care (POC) in vitro diagnostic (IVD) tests and screening systems. Some of the companies profiled include:

  • Nova Biomedical
  • Philips Healthcare
  • Siemens Healthcare
  • Somagen Diagnostics
  • GE Healthcare
  • GenMark Diagnostics
  • Hologic
  • Immco Diagnostics
  • Luminex

Sales projections are modeled on an investigation of today’s market conditions and on investigations into the development of new products by top tier competitors. The information offered in this study is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives and researchers.

Table of Contents

1.0 Executive Summary

1.1 Methodology

2.0 Introduction

2.1 Female Health: Room for Improvement

2.2 Perspective on Women’s Health

2.3 The Way Women and Men Develop Disease Is Different

2.3.1 Pain

2.3.2 The Heart

2.3.3 The Brain

2.3.4 Emotions

2.3.5 Bone Structure

2.3.6 Alcohol

2.3.7 Drug Side Effects

2.3.8 Smoking

2.3.9 Fertility

2.3.10 STIs/HIV

2.3.11 Autoimmune Disease

2.3.12 Cancer

2.3.13 Musculoskeletal Health

2.3.14 Birth Defects

2.3.15 Urinary Tract Infections

2.4 Key Leading Causes of Death in Females

2.5 Demographics

2.6 What Claims Women’s Lives

2.7 Key Trends and Issues in Women’s Diagnostics

2.7.1 OVA1

2.7.2 CA-125

2.7.3 HER2

2.8 Understanding the Molecular Basis of Disease

2.8.1 Managing Cancer Disease and Costs through Reimbursement

2.8.2 Ultrasound and Mammography Use Grows

3.0 Market Developments in Women’s Health Diagnostics

3.1 Quest and Hologic Team Up

3.2 Quest Genetic Testing for Breast Cancer Risk

3.3 Sequenom, Quest Collaborate on Noninvasive Prenatal Testing

3.4 Partnering to Make Personalized Infertility Treatment Possible

3.5 Co-Marketing of Full-Length HLA Gene Sequencing Products

3.6 Acquisition Strengthens Theranostics Development

3.7 Trinity Biotech Acquisition

3.8 Noninvasive Prenatal Test Significantly Reduces False Positive Rate

3.9 Proteome Sciences, Fisher Scientific Sign Agreement on Cancer Tests

3.10 Agreement on Fetal and Maternal Monitoring Software

3.11 Distribution Agreement for OTC Women’s Health Diagnostics

3.12 Women’s Health Cancer Diagnostics Company Raises $11.3 Million

3.13 Crowd Funding for At-Home Breast Exam Device

3.14 $13M Series A Round for Ultrasound Fibroid Device

3.15 FDA Clears Femur Fracture Test

3.16 FDA 510(k) Clearance for Female Incontinence Device

3.17 GE PMA for extended labeling for Senographe Mammography

3.18 FDA Clears MicroDose Mammography

3.19 FDA ABUS Approval

3.20 FDA Approval for Imaging Software System for Ultrasound

3.21 EU Nod for Breast Tissue Screening System

3.22 Cervical Cancer Screening Test Concerns

3.23 New Smartphone App Detects Newborn Jaundice in Minutes

4.0 Pregnancy and Ovulation

Key Trend

4.1 Perspective on Testing

4.1.1 Digital Testing

4.1.2 Testing for Placental Growth Factor and Pre-eclampsia

4.1.3 Lab Developed Tests

4.2 OTC Pregnancy Self-Test Market

4.3 Lab-Based Fertility Testing Market

4.4 Lab-Based Torch Testing Market

4.5 Abbott Diagnostics

4.6 Alere Inc.

4.7 biomerieux SA

4.8 Church & Dwight Co. Inc

4.9 Dialab GMBH

4.10 Prestige Diagnostics

4.11 Roche Diagnostics

4.12 Siemens Healthcare Diagnostics

5.0 Bone Density Testing

Key Trend

5.1 Alarming Rise of Osteoporosis

5.2 Propelling the Need for Detection

5.3 DEXA and Competing Technologies

5.4 Bone Densitometer Market

5.5 GE Healthcare

5.6 Hologic

5.7 Osteometer MediTech

6.0 Prenatal Screening

Key Trend

6.1 Invasive Testing

6.2 Noninvasive Testing

6.3 The Impact of Prenatal Genetic Testing

6.4 DNA Assay Market

6.5 Prenatal Carrier and Fetus Screening Market

6.6 PerkinElmer

6.7 Quest Diagnostics

6.8 ScreenCell

6.9 Sequenom

6.10 Laboratory Corporation of America

7.0 Ultrasound

Key Trend

7.1 History and Perspective

7.2 Nuchal Translucency

7.3 Speckle Reduction

7.4 Volumetric Imaging

7.5 Follicular Tracking

7.6 Obstetrics and Gynecology

7.7 Breast Imaging

7.8 Ob/Gyn Market

7.9 Breast Imaging Market

7.10 Analogic

7.11 Philips Healthcare

7.12 Siemens Healthcare

7.13 GE Healthcare

7.14 Hitachi Aloka Medical Ltd.

7.15 Supersonic Imagine

8.0 Mammography

Key Trend

8.1 Perspective

8.1.1 Economics of Routine Screening

8.2 Transitioning to Digital

8.3 Computer-Aided Detection

8.3.1 A Second Opinion

8.3.2 Analyzing Tumor Characteristics

8.4 Mammography Systems Market

8.5 CAD Market

8.6 Carestream Health

8.7 FujiFilm Medical Systems USA

8.8 GE Healthcare

8.9 Hologic

8.10 iCAD Inc

8.11 Parascript LLC

8.12 R2 Technology

9.0 Pap Smears

Key Trend

9.1 Testing for Cervical Cancer

9.1.1 Types of Screening

9.2 Cervical Cancer Vaccines

9.3 A Market Need

9.4 IVD Market

9.5 BD

9.6 BioReference Laboratories

9.7 BioSciCon

9.8 Hologic

9.9 Innogenetics NV

10.0 Colposcopy

Key Trend

10.1 Colposcopy Biopsy

10.2 Abnormal Pap Smear Results

10.3 Routine Use But Mature Market

10.3.1 Primary and Secondary Screening

10.4 Colposcopy Systems Market

10.5 CooperSurgical

10.6 DySIS Medical

10.7 Guided Therapeutics

10.8 Leisegang

10.9 NeoDiagnostix

11.0 HPV Testing

Key Trend

11.1 HPV Infection

11.1.1 Infection in Females

11.1.2 High Risk Types

11.1.3 HPV Major Cause of Cervical Cancer

11.2 HPV Test

11.3 Vaccine Issues

11.4 Strong Market Expected

11.4.1 IVD Market

11.5 Abbott Molecular

11.6 Hologic

11.7 Qiagen Benelux BV

11.8 Roche Diagnostics

12.0 Ovarian Cancer

Key Trend

12.1 Types of Ovarian Cancer

12.2 Pelvic Examinations

12.3 Tumor Markers, AFP, HE4

12.4 CA-125 Antigen

12.5 CA-125 Market

12.6 Avant Diagnostics Inc.

12.7 Biosystems International

12.8 Fujirebio Diagnostics

12.9 Myriad Genetics Inc.

13.0 Urinary Tract Infections

Key Trend

13.1 Leading Cause of Morbidity and Death

13.1.1 Impact

13.1.2 Impact on Women

13.1.3 E. coli the Key Culprit

13.2 UTI Molecular Testing Market

13.3 i-Health Inc.

13.4 Liofilchem

13.5 Rheonix

13.6 Somagen Diagnostics

14.0 Neonatal Jaundice

Key Trend

14.1 Issues Involving Bilirubin

14.2 Two Factors in Neonates

14.3 Risk Factors

14.4 Smart Phone App

14.5 Bilirubin Testing Market

14.6 Instrumentation Laboratory

14.7 Nova Biomedical

14.8 Siemens Healthcare Diagnostics

14.9 Wako Diagnostics

14.10 Roche Diagnostics

15.0 Autoimmune Disease

Key Trend

15.1 Types of Autoimmune Disease

15.2 Genetic Factors

15.3 Impact on Females

15.4 Female Lab-Based Immunoassay Autoimmune Testing Market

15.5 Aesku.Diagnostics

15.6 AXA Diagnostics SRL

15.7 Bio-Rad Laboratories

15.8 Euroimmun AG

15.9 Immco Diagnostics

15.10 Kronus

15.11 Phadia

15.12 XDx

16.0 Cystic Fibrosis

Key Trend

16.1 Affecting the Entire Body

16.2 Reduced Life Expectancy

16.3 Genetics

16.4 Chronic Infections

16.5 Females Worse Than Males

16.6 Genetic Testing Market

16.7 AutoGenomics

16.8 GenMark Diagnostics

16.9 Illumina

16.10 Luminex

16.11 ScheBo – Biotech AG

16.12 Sequenom

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
qPCR and dPCR Markets: Forecasts to 2018 (Instruments, Reagents, Software/Services,...Syringe Infusion Pumps: World Market Analysis, Forecasts to 2018
Scroll to top